Connect Biopharma Holdings Limited Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration
Connect Biopharma Holdings Limited (CNTB) had Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration of $1.10 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Alternative
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration $1.10M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration $1.00M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration |
|---|---|
| 2025-12-31 | $1.10M 10-K · filed 2026-03-31 |
| 2024-12-31 | $1.00M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |